Descriptive statistics of the three outcome measures
| Outcome | Amoxicillin | Placebo |
|---|---|---|
| Mean symptom severity between days 2 and 4 postrandomisation* | 1.6 (0.8) | 1.7 (0.8) |
| Development of new or worsening symptoms in the 4 weeks postrandomisation | 162/1021 (15.9) | 194/1006 (19.3) |
| Reported non-respiratory symptoms/side effects in the 4 weeks postrandomisation | 249/867 (28.7) | 206/860 (24.0) |
Data are n/N (%) or mean (SD).
*Each symptom was scored from 0–6 (0=no problem, 1=very little problem, 2=slight problem, 3=moderately bad, 4=bad, 5=very bad, 6=as bad as it could be).